Evaluation of Sorrento Therapeutics' Natural Killer Cells for COVID-19 Treatment

Project: Research project

Project Details

StatusFinished
Effective start/end date3/11/203/1/24

Funding

  • Sorrento Therapeutics Inc: $1,132,048.00